What are the best treatments for Adult-onset Stills Disease?

TL;DR: Treatment for Adult-onset Still's Disease (AOSD) typically begins with corticosteroids and disease-modifying antirheumatic drugs (DMARDs) to manage systemic inflammation, often transitioning to biologic therapies if symptoms persist. Because the disease affects multiple organ systems, care must be personalized by a multidisciplinary team led by a rheumatologist to address individual symptom profiles and prevent long-term joint damage.

What are the primary treatments for Adult-onset Still's Disease?

The management of Adult-onset Still's Disease is highly individualized, as the condition can range from a self-limiting single episode to a chronic, relapsing, or progressive systemic illness. First-line therapy generally involves the use of high-dose corticosteroids (such as prednisone) to rapidly suppress the systemic inflammation, including the characteristic high-spiking fevers and salmon-colored rash. For patients who do not achieve remission with steroids alone, or who require long-term management to prevent joint destruction, conventional synthetic DMARDs like methotrexate are often introduced. In cases of refractory Adult-onset Still's Disease, clinicians may prescribe biologic agents that target specific inflammatory cytokines, such as interleukin-1 (IL-1) inhibitors (e.g., anakinra, canakinumab) or interleukin-6 (IL-6) inhibitors (e.g., tocilizumab).

What non-pharmacological support is needed for Adult-onset Still's Disease?

Beyond systemic medication, managing the physical impact of Adult-onset Still's Disease requires a holistic approach to preserve mobility and quality of life. Patients experiencing chronic joint pain and muscle stiffness may benefit significantly from the following supportive therapies:

• Physical Therapy: Focused on maintaining range of motion and strengthening muscles around affected joints to reduce the risk of permanent joint destruction.


• Occupational Therapy: Assists in developing strategies for daily activities, particularly when inflammation impacts hand or wrist function.


• Pain Management: Techniques such as heat/cold therapy and low-impact exercise can help manage muscle pain and fatigue during periods of lower disease activity.


• Nutritional Support: Maintaining a balanced diet is essential to combat the systemic nature of the disease and counteract potential side effects of long-term steroid use, such as bone density loss.

Which specialists should be on the care team?

Because Adult-onset Still's Disease is a systemic inflammatory condition affecting the circulatory, respiratory, and urinary systems, a multidisciplinary approach is vital. The core of your care team should include a rheumatologist who specializes in autoinflammatory conditions. Depending on your specific symptoms, your team may also include a cardiologist for heart-related inflammation, a pulmonologist for pleurisy, a nephrologist for kidney involvement, and a clinical psychologist to help manage the emotional burden of living with a chronic, rare disease. Currently, 689 members of the DiseaseMaps community have shared their experiences with Adult-onset Still's Disease, highlighting the value of peer support alongside professional clinical care.

Are there emerging treatments for Adult-onset Still's Disease?

Medical research into Adult-onset Still's Disease is evolving rapidly, with a focus on precision medicine. Clinical trials are currently exploring the long-term efficacy of various biologics and JAK inhibitors to better control the disease while minimizing the side effects associated with chronic steroid use. Because the disease is rare, participating in clinical research or registries can provide access to emerging therapies and contribute to a better understanding of the condition's progression.

Next steps

• Consult a board-certified rheumatologist to develop a personalized, step-by-step treatment plan tailored to your specific organ involvement.


• Keep a detailed symptom diary, noting the timing of your daily fevers and the appearance of the salmon-colored rash, to share during appointments.


• Join the DiseaseMaps.org community to connect with other patients and share experiences regarding treatment efficacy and coping strategies.


• Discuss with your physician whether you are a candidate for clinical trials currently investigating new therapeutic pathways for systemic inflammatory diseases.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; please consult your healthcare team for personalized medical decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Adult-onset Still's Disease


• Orphanet: Portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man) - Still Disease, Adult-onset


• Arthritis Foundation - Information on systemic inflammatory conditions